For pathway analysis, 47 gene targets in the COVID-19 and CQ/HCQ drug-gene network were mostly enriched in TLR signaling pathway (GO: 0002224) and nuclear factor kappa light chain enhancer of activated B cells (NF-κB) signaling pathway (GO: 0038061) (Figure 3B). This evidence concerns the gene NFKB1 and COVID-19.